Small intrahepatic mass-forming cholangiocarcinoma: Target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma

Abdominal Imaging

Volumn 38, Issue 4, 2013, Pages 793-801

  Park, Hyun Jeong ^a   Kim, Young Kon ^a   Park, Min Jung ^a   Lee, Won Jae ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Cholangiocarcinoma; Diffusion weighted imaging; Gd EOB DTPA; Hepatocellular carcinoma; Liver

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT DILATATION; CHRONIC LIVER DISEASE; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; FEMALE; FISHER EXACT TEST; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MASS FORMING INTRAHEPATIC CHOLANGIOCARCINOMA; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADENOCARCINOMA; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84882256548     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-012-9943-x     Document Type: Article

References (28)

1. Kham SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303-1314
2. Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33:1353-1357
3. Shaib Y, El-Serag HB (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115-125
4. Lim JH (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 181:819-827
5. Choi BI, Han JK, Shin YM, Baek SY, Han MC (1995) Peripheral cholangiocarcinoma: comparison of MRI with CT. Abdom Imaging 20:357-360
6. Fan ZM, Yamashita Y, Harada M, et al. (1993) Intrahepatic cholangiocarcinoma: spin-echo and contrast-enhanced dynamic MR imaging. AJR Am J Roentgenol 161:313-317
7. Hamrick-Turner J, Abbitt PL, Ros PR (1992) Intrahepatic cholangiocarcinoma: MR appearance. AJR Am J Roentgenol 158:77-79
8. Maetani Y, Itoh K, Watanabe C, et al. (2001) MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 176:1499-1507
9. Tani K, Kubota Y, Yamaguchi T, et al. (1991) MR imaging of peripheral cholangiocarcinoma. J Comput Assist Tomogr 15:975-978
10. Vilgrain V, Van Beers BE, Flejou JF, et al. (1997) Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 21:59-65
11. Rimola J, Forner A, Reig M, et al. (2009) Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 50:791-798
12. Vilana R, Forner A, Bianchi L, et al. (2010) Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 51:2020-2029
13. Kim SA, Lee JM, Lee KB, et al. (2011) Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern-correlation with clinicopathologic findings. Radiology 260:148-157
14. Kim SJ, Lee JM, Han JK, et al. (2007) Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR Am J Roentgenol 189:1428-1434
15. El-Serag HB, Engels EA, Landgren O, et al. (2009) Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology 49:116-123
16. Bruix J, Sherman M, American Association for the Study of Liver Disease (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020-1021
17. Bruix J, Sherman M, Llovet JM, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421-430
18. Kim YK, Kim CS, Han YM, Park G (2010) Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging? Invest Radiol 45:740-746
19. Kim SH, Kim SH, Lee J, et al. (2009) Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192:1675-1681
20. Kim YK, Kim CS, Han YM, et al. (2009) Detection of hepatocellular carcinoma: gadoxetic acid-enhanced 3-dimensional magnetic resonance imaging versus multi-detector row computed tomography. J Comput Assist Tomogr 33:844-850
21. Taouli B, Koh DM (2010) Diffusion-weighted MR imaging of the liver. Radiology 254:47-66
22. Kim YK, Lee MW, Lee WJ, et al. (2012) Diagnostic accuracy and sensitivity of diffusion-weighted and gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤1.5 cm in diameter). Invest Radiol 47:159-166
23. Bolondi L, Gaiani S, Celli N, et al. (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27-34
24. Holland AE, Hecht EM, Hahn WY, et al. (2005) Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 237:938-944
25. Kim YK, Lee JM, Kim CS (2004) Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 14:5-13
26. Tamada T, Ito K, Sone T, et al. (2009) Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging 29:636-640
27. Gabata T, Matsui O, Kadoya M, et al. (1998) Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging 23:309-313
28. Kim YK, Han YM, Kim CS (2009) Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI. Eur J Radiol 70:94-100